<DOC>
	<DOCNO>NCT01675362</DOCNO>
	<brief_summary>This study conduct evaluate protective effect mechanisms antioxidant ( vitamins A , C , E Selenium ) , calcium channel blocker ( Verapamil ) angiotensin receptor blocker ( Lozartan ) shock wave induce renal injury .</brief_summary>
	<brief_title>Are There Protective Effects Antioxidants , Calcium Channel Blocker Angiotensin Receptor Blocker Against Extracorporeal Shockwaves Lithotripsy Induced Renal Injury ?</brief_title>
	<detailed_description>The protective effect evaluate via estimation change renal tubular enzyme ( NGAL ) detection albumen level urine . The mechanisms protection investigate estimation renal perfusion functional change use dynamic MRI .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Selenium</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<mesh_term>Verapamil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Calcium Channel Blockers</mesh_term>
	<mesh_term>Angiotensin Receptor Antagonists</mesh_term>
	<criteria>1 . Well function kidney ( serum creatinine &lt; 1.2 mg/dl ) . 2 . Solitary renal stone . 3 . Size : 25 mm less large diameter . 1 . Contraindications ESWL 2 . Previous surgical treatment renal stone . 3 . Congenital renal anomaly . 4 . Pediatric patient ( age &lt; 18 year ) . 5 . Patients Diabetes hypertension</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Extracorporeal shockwave lithotripsy ( ESWL )</keyword>
	<keyword>Kidney calculus</keyword>
	<keyword>Renal protection</keyword>
	<keyword>Antioxidants</keyword>
	<keyword>Calcium channel blocker</keyword>
	<keyword>Angiotensin receptor blocker</keyword>
</DOC>